This review summarizes strategies to enhance targeted delivery of cancer vaccines, highlighting advances in immunotherapy and vaccine vector efficiency.
Key Points
TARGETED DELIVERY: Enhanced delivery systems improve the effectiveness of cancer vaccines and immunotherapy.
IMMUNE RESPONSE: Triggering tumor-specific T-cell responses is vital for achieving targeted cytotoxicity against tumors.
CHALLENGES: Drug resistance and immunosuppression in the tumor microenvironment limit treatment efficacy.
CURRENT TRENDS: Key strategies for vaccine vector targeting involve innovative approaches to overcome existing barriers.